Document is current
Any future updates will be listed below
-
Authors
Vorbach, Samuel M. https://orcid.org/0009-0003-1711-1604
Seppi, Thomas
Santo, Giulia https://orcid.org/0000-0001-6565-0686
Virgolini, Irene https://orcid.org/0000-0001-7097-6170
Ganswindt, Ute
Keilholz, Michael
Brose, Sarah Frederike
Casuscelli, Jozefina
Klimek, Konrad
Werner, Rudolf A.
Schmidt-Hegemann, Nina-Sophie
Belka, Claus
Trapp, Christian
Rogowski, Paul https://orcid.org/0000-0003-3351-8896
-
Funding
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
- License Information
-
More Information
Article History
Received: 8 June 2026
Accepted: 17 August 2026
First Online: 4 September 2026
Declarations
Ethics approval: The study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments and was approved by the Institutional Ethics Committees of the Medical University of Innsbruck (approval number 1092/2024) and of the Medical Faculty at the LMU Munich (approval number 19–361).
Competing interests: RAW reports advisory board work for and has received speaker honoraria from Novartis. All other authors declare that they have no financial or non-financial conflicts of interest. This study was performed in accordance with the local ethical standards.
